De Braud Filippo Guglielmo Maria

PATIENT VOICES, a project for the integration of the systematic assessment of patient reported outcomes and experiences within a comprehensive cancer center: a protocol for a mixed method feasibility study / C. Brunelli, C. Borreani, A. Caraceni, A. Roli, M. Bellazzi, L. Lombi, E. Zito, C. Pellegrini, P. Spada, S. Kaasa, A.M. Foschi, G. Apolone, M. Bellazzi, F. Belli, C. Borreani, C. Brunelli, G. Capri, A. Caraceni, P. Casali, P. Corradini, F. De Braud, A.M. Foschi, S. Folli, M. Garassino, L. Licitra, N. Nicolai, C. Pellegrini, M. Platania, G. Procopio. - In: HEALTH AND QUALITY OF LIFE OUTCOMES. - ISSN 1477-7525. - 18:1(2020 Jul 28).

Rapid Antibody Testing for SARS-CoV-2 in Asymptomatic and Paucisymptomatic Healthcare Professionals in Hematology and Oncology Units Identifies Undiagnosed Infections / P. Corradini, G. Gobbi, F. de Braud, J. Rosa, C. Rusconi, G. Apolone, C. Carniti. - In: HEMASPHERE. - ISSN 2572-9241. - 4:3(2020 Jun).

Systemic Treatment of Patients With Gastrointestinal Cancers During the COVID-19 Outbreak : COVID-19-adapted Recommendations of the National Cancer Institute of Milan / F. Pietrantonio, F. Morano, M. Niger, S. Corallo, M. Antista, A. Raimondi, M. Prisciandaro, F. Pagani, N. Prinzi, F. Nichetti, G. Randon, M. Torchio, F. Corti, M. Ambrosini, F. Palermo, M. Palazzo, L. Biamonte, M. Platania, C. Sposito, M. Cosimelli, V. Mazzaferro, S. Pusceddu, C. Cremolini, F. de Braud, M. Di Bartolomeo. - In: CLINICAL COLORECTAL CANCER. - ISSN 1533-0028. - (2020 May 23). [Epub ahead of print]

Clinical Behavior and Treatment Response of Epstein-Barr Virus–Positive Metastatic Gastric Cancer : Implications for the Development of Future Trials / S. Corallo, G. Fuca, F. Morano, M. Salati, A. Spallanzani, A. Gloghini, C.C. Volpi, D.V. Trupia, R. Lobefaro, V. Guarini, M. Milione, L. Cattaneo, M. Antista, M. Prisciandaro, A. Raimondi, C. Sposito, V. Mazzaferro, F. de Braud, F. Pietrantonio, M. Di Bartolomeo. - In: THE ONCOLOGIST. - ISSN 1083-7159. - 25(2020 Apr 09), pp. 1-7. [Epub ahead of print]

Entrectinib in ROS1 fusion-positive non-small-cell lung cancer: integrated analysis of three phase 1–2 trials / A. Drilon, S. Siena, R. Dziadziuszko, F. Barlesi, M.G. Krebs, A.T. Shaw, F. de Braud, C. Rolfo, M. Ahn, J. Wolf, T. Seto, B.C. Cho, M.R. Patel, C. Chiu, T. John, K. Goto, C.S. Karapetis, H. Arkenau, S. Kim, Y. Ohe, Y. Li, Y.K. Chae, C.H. Chung, G.A. Otterson, H. Murakami, C. Lin, D.S.W. Tan, H. Prenen, T. Riehl, E. Chow-Maneval, B. Simmons, N. Cui, A. Johnson, S. Eng, T.R. Wilson, R.C. Doebele. - In: LANCET ONCOLOGY. - ISSN 1470-2045. - 21:2(2020 Feb), pp. 261-270.